Overview

• The park attracted €124 million in 2024, its second-highest haul ever, with €97.5 million from private investors and €27.2 million in public capital.
• Inbrain Neuroelectronics led the 86 on-site ventures by raising €78 million to develop graphene-based therapies for neurological disorders.
• Full occupancy across 34,000 m² of labs and offices has driven interim conversions of maintenance space into research facilities to meet urgent demand.
• The site is anchoring Barcelona’s new Diagonal health corridor ahead of a €1.7 billion Hospital Clínic and Faculty of Medicine expansion scheduled for 2035.
• Park officials are targeting researchers displaced by restrictive US policies, hoping to offer a rapid, coordinated European alternative.